Edition:
United States

Shanghai Tofflon Science and Technology Co Ltd (300171.SZ)

300171.SZ on Shenzhen Stock Exchange

13.37CNY
30 Mar 2017
Change (% chg)

¥-0.26 (-1.91%)
Prev Close
¥13.63
Open
¥13.60
Day's High
¥13.61
Day's Low
¥13.32
Volume
2,548,840
Avg. Vol
3,369,262
52-wk High
¥22.82
52-wk Low
¥13.05

Latest Key Developments (Source: Significant Developments)

Shanghai Tofflon Science and Technology sees 2016 H1 net profit to decrease by 10 percent to 30 percent
Tuesday, 19 Jul 2016 05:55am EDT 

Shanghai Tofflon Science and Technology Co Ltd <300171.SZ> :Sees 2016 H1 net profit to decrease by 10 percent to 30 percent, compared to net profit of H1 of 2015(198.8 million yuan).  Full Article

Shanghai Tofflon Science and Technology to pay 2015 dividend on June 29
Thursday, 23 Jun 2016 01:55am EDT 

Shanghai Tofflon Science and Technology Co., Ltd. <300171.SZ>: Says it will pay cash dividend of 0.3 yuan per share (before tax) for 2015 to shareholders of A shares of record on June 28 .Says the company's shares will be traded ex-right and ex-dividend on June 29 and the dividend will be paid on June 29.  Full Article

Shanghai Tofflon Science and Technology announces 2015 dividend payment
Tuesday, 19 Apr 2016 08:00pm EDT 

Shanghai Tofflon Science and Technology Co Ltd:To use undistributed profits to pay cash dividend of 3 yuan per 10 shares (before tax) to shareholders for 2015.  Full Article

Shanghai Tofflon Science and Technology to transfer 51.72 pct stake in Shanghai Divine Medical Technology
Tuesday, 19 Apr 2016 08:00pm EDT 

Shanghai Tofflon Science and Technology Co Ltd:To transfer 51.72 pct stake in Shanghai Divine Medical Technology Co Ltd to a Shanghai-based medical technology development company at 33.75 million yuan.The Shanghai-based medical technology development company to hold 79.72 pct stake in Shanghai Divine Medical Technology after transfer.  Full Article

Shanghai Tofflon Science and Technology issues 2016 Q1 net profit outlook
Friday, 8 Apr 2016 04:02am EDT 

Shanghai Tofflon Science and Technology Co Ltd:Sees net profit for 2016 Q1 to decrease 0 ~20 pct, or to be 81,059,800 yuan to 101,324,700 yuan.Says the net profit of 2015 Q1 was 101,324,700 yuan.Comments that market demands decrease and market aggravating competition are the main reasons for the forecast.  Full Article

Shanghai Tofflon Science and Technology completes to acquire stake in subsidiary
Monday, 21 Mar 2016 04:01am EDT 

Shanghai Tofflon Science and Technology Co Ltd:Completed acquiring 40 pct stake in a Shanghai-based pharmaceutical equipment subsidiary from eight individuals at 36 million yuan.Holds 100 pct stake in the subsidiary at present.  Full Article

Shanghai Tofflon Science and Technology to acquire stake in subsidiary
Tuesday, 1 Mar 2016 02:51am EST 

Shanghai Tofflon Science and Technology Co Ltd:To acquire 40 pct stake in a Shanghai-based pharmaceutical equipment subsidiary from eight individuals at 36 million yuan.To hold 100 pct stake in the subsidiary after acquisition.  Full Article

Shanghai Tofflon Science and Technology gives 2015 net profit outlook
Friday, 8 Jan 2016 03:17am EST 

Shanghai Tofflon Science and Technology Co Ltd:Sees net profit for 2015 to increase 10 pct to 30 pct, or to be 368.9522 million yuan to 436.0344 million yuan.Says the net profit of 2014 was 335.4111 million yuan.Comments the development of business is the main reason for the forecast.  Full Article

Shanghai Tofflon Science and Technology signs strategic cooperation agreement
Thursday, 31 Dec 2015 02:51am EST 

Shanghai Tofflon Science and Technology Co Ltd:Signed strategic cooperation agreement with Chongqing Dadukou district people's government on Dec. 31.To cooperate on construction of Chongqing precision medical innovation entrepreneurial platform.  Full Article

Shanghai Tofflon Science and Technology issues Q1 to Q3 2015 net profit outlook
Tuesday, 13 Oct 2015 04:03am EDT 

Shanghai Tofflon Science and Technology Co Ltd:Sees net profit for Q1 to Q3 of 2015 to increase 0 pct to 30 pct, or to be 219.8182 million yuan to 285.7637 million yuan.Says the net profit of Q1 to Q3 of 2014 was 219.8182 mln yuan.Comments that precision medical related industry development and stake acquisition are the main reasons for the forecast.  Full Article

More From Around the Web